Biosergen AS (BIOSGN) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.954x

Based on the latest financial reports, Biosergen AS (BIOSGN) has a cash flow conversion efficiency ratio of -0.954x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-7.75 Million ≈ $-833.70K USD) by net assets (Skr8.12 Million ≈ $873.52K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Biosergen AS for the company's overall valuation and market capitalisation.

Biosergen AS - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Biosergen AS's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Biosergen AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biosergen AS ranked by their cash flow conversion efficiency. See Biosergen AS cash debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Boostheat PA:ALBOO	-8.082x
Akoustis Technologies, Inc. NASDAQ:AKTSQ	0.187x
Cheetah Net Supply Chain Service Inc. Class A Common Stock NASDAQ:CTNT	0.020x
SCANDION ONC. DK-0735 F:8VY	N/A
Greiffenberger AG F:GRF	0.089x
Mosman Oil and Gas Ltd LSE:MSMN	-0.118x
Cerinnov Group SA PA:ALPCV	0.999x
LORDS CO. WORLDW. HOLD. F:4XM	N/A

Annual Cash Flow Conversion Efficiency for Biosergen AS (2019–2025)

The table below shows the annual cash flow conversion efficiency of Biosergen AS from 2019 to 2025. View Biosergen AS stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr8.12 Million ≈ $873.52K	Skr-35.53 Million ≈ $-3.82 Million	-4.378x	-1193.49%
2024-12-31	Skr49.14 Million ≈ $5.29 Million	Skr-16.63 Million ≈ $-1.79 Million	-0.338x	+97.80%
2023-12-31	Skr2.12 Million ≈ $227.72K	Skr-32.60 Million ≈ $-3.51 Million	-15.408x	-1092.92%
2022-12-31	Skr22.79 Million ≈ $2.45 Million	Skr-29.44 Million ≈ $-3.17 Million	-1.292x	+30.77%
2021-12-31	Skr20.23 Million ≈ $2.18 Million	Skr-37.75 Million ≈ $-4.06 Million	-1.866x	-544.61%
2020-12-31	Skr-10.92 Million ≈ $-1.18 Million	Skr-4.58 Million ≈ $-493.31K	0.420x	-14.94%
2019-12-31	Skr-4.69 Million ≈ $-504.90K	Skr-2.31 Million ≈ $-249.07K	0.493x	--

About Biosergen AS

ST:BIOSGN Sweden Biotechnology

Market Cap

$137.73K

Skr1.28 Million SEK

Market Cap Rank

#31416 Global

#740 in Sweden

Share Price

Skr0.55

Change (1 day)

-0.91%

52-Week Range

Skr0.45 - Skr50.40

All Time High

Skr50.40